Free weekly newsletter

Get the free weekly executive digest

The new leadership moves, who’s behind them, and what they mean — delivered to your inbox every week. No credit card, unsubscribe anytime.

Weekly Digest

New leadership moves, summarized for you

Straight to Inbox

No login, no app to check — it comes to you

Leadership Trends

See who's moving and how much in your market

No credit card required Weekly executive digest

Immuno Precise Antibodies Appoints Kristin Taylor As Chief Financial Officer

RECENTLY ACQUIREDJun 27, 2024•almost 2 years ago

Company

ImmunoPrecise Antibodies (Europe) B.V

VictoriaBiotechnologyTherapeutics

Description

ImmunoPrecise Antibodies Ltd. (IPA) has announced the appointment of Kristin Taylor as Chief Financial Officer, effective immediately

Company Information

Company

ImmunoPrecise Antibodies (Europe) B.V

Location

Victoria, British Columbia, Canada

About

ImmunoPrecise Antibodies (Europe) B.V. specializes in antibody discovery, engineering, and characterization services. It operates in Europe and has advanced capabilities for recombinant protein expression. The company is a carve-out from ImmunoPrecise Antibodies Ltd.

Related People

Suggested for you

Choose your plan to reveal verified contacts

Predictive Intelligence

Strategic

ML-powered predictions for ImmunoPrecise Antibodies (Europe) B.V's next move

Learn about Strategic plan

Executive Insights

Based on hiring data

New executive impact window

87% of new executives make significant technology decisions within first 100 days

Budget influence

C-level executives control 73% of technology spending decisions

Transformation catalyst

65% of new senior hires launch digital transformation initiatives

Vendor review timeline

New executives typically review existing vendors within 6 months